A Randomized, Open-label Trial of Paritaprevir Plus Ritonavir Plus Ombitasvir in the Treatment of HCV Genotype 4 Infected Patients with Stage 4-5 Chronic Kidney Disease
2020-07-04
عنوان الدراسة
A Randomized, Open-label Trial of Paritaprevir Plus Ritonavir Plus Ombitasvir in the Treatment of HCV Genotype 4 Infected Patients with Stage 4-5 Chronic Kidney Disease
داعم الدراسة
Abbvie Biopharmaceuticals GmbH / KSU Liver Disease Research Center
دواء الدراسة
ombitasvir \ paritaprevir \ ritonavir
رقم بروتوكول الدراسة
Version 1.3.1
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。